These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 17727739)
1. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy. Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739 [TBL] [Abstract][Full Text] [Related]
2. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy. Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736 [TBL] [Abstract][Full Text] [Related]
3. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Zeng K; Wang X; Xi Z; Yan Y Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075 [TBL] [Abstract][Full Text] [Related]
4. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068 [TBL] [Abstract][Full Text] [Related]
5. Assessment of tolerability in elderly patients: changing to lamotrigine therapy. Evans BK; Kustra RP; Hammer AE Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513 [TBL] [Abstract][Full Text] [Related]
6. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy. Stephen LJ; Sills GJ; Leach JP; Butler E; Parker P; Hitiris N; Leach VM; Wilson EA; Brodie MJ Epilepsy Res; 2007 Jul; 75(2-3):122-9. PubMed ID: 17553671 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191 [TBL] [Abstract][Full Text] [Related]
8. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy. Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248 [TBL] [Abstract][Full Text] [Related]
9. How to replace lamotrigine with valproate. Steinhoff BJ Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036 [TBL] [Abstract][Full Text] [Related]
10. Conversion from immediate-release to extended-release lamotrigine improves seizure control. Ramey P; Osborn M; Abou-Khalil B Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy. Gidal BE; Sheth R; Parnell J; Maloney K; Sale M Epilepsy Res; 2003 Dec; 57(2-3):85-93. PubMed ID: 15013050 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941 [TBL] [Abstract][Full Text] [Related]
13. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Brodie MJ; Yuen AW Epilepsy Res; 1997 Mar; 26(3):423-32. PubMed ID: 9127723 [TBL] [Abstract][Full Text] [Related]
14. Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels. Fröscher W; Keller F; Vogt H; Krämer G Epileptic Disord; 2002 Mar; 4(1):49-56. PubMed ID: 11967180 [TBL] [Abstract][Full Text] [Related]
15. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy. Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293 [TBL] [Abstract][Full Text] [Related]
16. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy. Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401 [TBL] [Abstract][Full Text] [Related]
17. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy. Jozwiak S; Terczynski A Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873 [TBL] [Abstract][Full Text] [Related]
18. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878 [TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents. Mazurkiewicz-Bełdzińska M; Szmuda M; Matheisel A Seizure; 2010 Apr; 19(3):195-7. PubMed ID: 20167512 [TBL] [Abstract][Full Text] [Related]
20. Effect of comedication on lamotrigine clearance in Korean epilepsy patients. Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]